Innate Pharma SA Class AInnate Pharma SA Class AInnate Pharma SA Class A

Innate Pharma SA Class A

No trades
See on Supercharts

Price target

6.310.000.00%
The 2 analysts offering 1 year price forecasts for IDD have a max estimate of — and a min estimate of —.

Analyst rating

Based on 2 analysts giving stock ratings to IDD in the past 3 months.

EPS

Reported
Estimate
Reported
Estimate
Surprise

Revenue

Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


IDD EPS for the last quarter is −0.31 EUR despite the estimation of −0.26 EUR. In the next quarter EPS is expected to reach −0.28 EUR. Track more of Innate Pharma SA Class A financials and stay on top of what is up with the company.
In the next quarter Innate Pharma SA Class A revenue is expected to reach ‪12.00 M‬ EUR. Check out Innate Pharma SA Class A revenue and earnings and make informed decisions.
According to analysts, IDD price target is 6.31 EUR with a max estimate of 6.92 EUR and a min estimate of 5.70 EUR. Check if this forecast comes true in a year, meanwhile watch Innate Pharma SA Class A stock price chart and keep track of the current situation with IDD news and stock market news.